TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,546,000 | +5.0% | 177,815 | 0.0% | 0.23% | +14.1% |
| Q4 2021 | $2,424,000 | -16.8% | 177,815 | 0.0% | 0.20% | -11.2% |
| Q3 2021 | $2,913,000 | -2.7% | 177,815 | 0.0% | 0.22% | +14.9% |
| Q2 2021 | $2,993,000 | -7.8% | 177,815 | 0.0% | 0.20% | +23.4% |
| Q1 2021 | $3,247,000 | -43.4% | 177,815 | -43.6% | 0.16% | -54.9% |
| Q4 2020 | $5,733,000 | +2.0% | 315,006 | 0.0% | 0.35% | -18.0% |
| Q3 2020 | $5,620,000 | -62.1% | 315,006 | -62.0% | 0.43% | -73.0% |
| Q2 2020 | $14,845,000 | +18.1% | 827,955 | 0.0% | 1.58% | -31.3% |
| Q1 2020 | $12,568,000 | -23.1% | 827,955 | 0.0% | 2.30% | +2.5% |
| Q4 2019 | $16,336,000 | +14.7% | 827,955 | 0.0% | 2.24% | +44.4% |
| Q3 2019 | $14,241,000 | -2.8% | 827,955 | 0.0% | 1.55% | +55.4% |
| Q2 2019 | $14,655,000 | -13.1% | 827,955 | 0.0% | 1.00% | -13.5% |
| Q1 2019 | $16,865,000 | – | 827,955 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |